NCT00224445 - Boosted Atazanavir and Truvada Given Once-Daily - BATON Study | Biotech Hunter

Enrollment

100

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

January 31, 2007

Study Completion Date

January 31, 2007

Conditions

HIV Infections

Interventions

DRUG

Truvada

Truvada (emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg tablet) administered orally once daily (QD)

DRUG

Atazanavir

Atazanavir 300 mg (given as two 150-mg capsules) administered orally QD

DRUG

Ritonavir

Ritonavir 100 mg capsule administered orally QD

Trial Locations (1)

Gilead Sciences, Inc., Foster City